Antibodies to watch in 2019
H Kaplon, JM Reichert - MAbs, 2019 - Taylor & Francis
For the past 10 years, the annual 'Antibodies to watch'articles have provided updates on key
events in the late-stage development of antibody therapeutics, such as first regulatory review …
events in the late-stage development of antibody therapeutics, such as first regulatory review …
[HTML][HTML] Antibodies to watch in 2019
H Kaplon, JM Reichert - mAbs, 2019 - ncbi.nlm.nih.gov
For the past 10 years, the annual 'Antibodies to watch'articles have provided updates on key
events in the late-stage development of antibody therapeutics, such as first regulatory review …
events in the late-stage development of antibody therapeutics, such as first regulatory review …
[引用][C] Antibodies to watch in 2019
H Kaplon, JM Reichert - mAbs, 2018 - cir.nii.ac.jp
Antibodies to watch in 2019 | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ
] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす 日本の博士 …
] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす 日本の博士 …
Antibodies to watch in 2019.
H Kaplon, JM Reichert - Mabs, 2018 - europepmc.org
For the past 10 years, the annual 'Antibodies to watch'articles have provided updates on key
events in the late-stage development of antibody therapeutics, such as first regulatory review …
events in the late-stage development of antibody therapeutics, such as first regulatory review …
Antibodies to watch in 2019
H Kaplon, JM Reichert - mAbs, 2019 - pubmed.ncbi.nlm.nih.gov
For the past 10 years, the annual'Antibodies to watch'articles have provided updates on key
events in the late-stage development of antibody therapeutics, such as first regulatory review …
events in the late-stage development of antibody therapeutics, such as first regulatory review …
[PDF][PDF] Antibodies to watch in 2019
H Kaplon, JM Reichert - 2018 - researchgate.net
For the past 10 years, the annual LAntibodies to watchL articles have provided updates on
key events in the late-stage development of antibody therapeutics, such as first regulatory …
key events in the late-stage development of antibody therapeutics, such as first regulatory …
Antibodies to watch in 2019.
H Kaplon, JM Reichert - Mabs, 2018 - europepmc.org
For the past 10 years, the annual 'Antibodies to watch'articles have provided updates on key
events in the late-stage development of antibody therapeutics, such as first regulatory review …
events in the late-stage development of antibody therapeutics, such as first regulatory review …